Tags

Type your tag names separated by a space and hit enter

Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
Cerebrovasc Dis 2008; 26(5):563-4CD

Authors+Show Affiliations

HeartDrug Research Laboratories, Johns Hopkins University, Towson, MD 21204, USA. heartdrug@aol.comNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18936537

Citation

Serebruany, Victor L., et al. "Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit Beyond Blood Pressure Lowering?" Cerebrovascular Diseases (Basel, Switzerland), vol. 26, no. 5, 2008, pp. 563-4.
Serebruany VL, Atar D, Hanley DF. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering? Cerebrovasc Dis. 2008;26(5):563-4.
Serebruany, V. L., Atar, D., & Hanley, D. F. (2008). Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering? Cerebrovascular Diseases (Basel, Switzerland), 26(5), pp. 563-4. doi:10.1159/000164555.
Serebruany VL, Atar D, Hanley DF. Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit Beyond Blood Pressure Lowering. Cerebrovasc Dis. 2008;26(5):563-4. PubMed PMID: 18936537.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering? AU - Serebruany,Victor L, AU - Atar,Dan, AU - Hanley,Dan F, Y1 - 2008/10/21/ PY - 2008/10/22/pubmed PY - 2009/1/24/medline PY - 2008/10/22/entrez SP - 563 EP - 4 JF - Cerebrovascular diseases (Basel, Switzerland) JO - Cerebrovasc. Dis. VL - 26 IS - 5 SN - 1421-9786 UR - https://www.unboundmedicine.com/medline/citation/18936537/Telmisartan_and_stroke_reduction_in_the_ONTARGET_trial:_benefit_beyond_blood_pressure_lowering L2 - https://www.karger.com?DOI=10.1159/000164555 DB - PRIME DP - Unbound Medicine ER -